Human papillomavirus sperm infection and assisted reproduction: a dangerous hazard with a possible safe solution

Hum Reprod. 2012 Apr;27(4):967-73. doi: 10.1093/humrep/des009. Epub 2012 Feb 7.

Abstract

Background: Human papillomavirus (HPV) infection has been demonstrated in the sperm of a large percentage of sexually active males and is associated with an impairment of sperm parameters, with a particular negative impact on sperm motility, suggesting a possible role in male infertility. Conventional sperm selection techniques have a low efficiency in removing HPV.

Methods: Evaluation of sperm parameters, terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling test to evaluate DNA fragmentation and fluorescence in situ hybridization or immunohistochemistry for HPV were performed on semen samples from infected patients (n= 22), control subjects (n= 13) and on pooled control sperm samples incubated with HPV16-L1 (HPV capsid), before and after direct swim-up and modified swim-up (with added Heparinase-III). Moreover, cytofluorimetry for HPV detection was performed in pooled sperm pre- and post-incubation with HPV 16-L1 before and after direct and modified swim-up. Statistical analysis was performed with a two-tailed Student's t-test.

Results: Direct swim-up reduces the number of HPV-infected sperm by ~24% (P< 0.01), while modified swim-up is able to remove completely HPV DNA both from naturally and artificially infected sperm. Enzymatic treatment with Heparinase-III tended to decrease sperm motility, viability and DNA integrity but the effects were not significant.

Conclusions: This study shows that Heparinase-III treatment seems not to affect spermatozoa in vitro and suggests that this treatment should be investigated further as a means of preparing sperm from patients who are infected with HPV in order to reduce the risk of HPV infection when using assisted reproduction techniques.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiviral Agents / pharmacology
  • DNA, Viral / drug effects
  • Female
  • Fertilization in Vitro / adverse effects
  • Fertilization in Vitro / methods*
  • Human papillomavirus 16 / drug effects
  • Human papillomavirus 16 / genetics
  • Human papillomavirus 16 / isolation & purification
  • Humans
  • In Situ Hybridization, Fluorescence
  • In Situ Nick-End Labeling
  • Male
  • Papillomavirus Infections / prevention & control
  • Papillomavirus Infections / transmission*
  • Polysaccharide-Lyases / adverse effects
  • Polysaccharide-Lyases / pharmacology
  • Semen Analysis
  • Spermatozoa / drug effects
  • Spermatozoa / virology*

Substances

  • Antiviral Agents
  • DNA, Viral
  • Polysaccharide-Lyases
  • heparitinsulfate lyase